{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:23:22Z","timestamp":1793744602957,"version":"4.6.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite the extensive scientific evidence accumulating on the epidemiological risk factors for non-alcoholic fatty liver disease (NAFLD), evidence exploring sex- and age-related differences remains insufficient. The present cross-sectional study aims to investigate possible sex differences in the prevalence of FLI-defined NAFLD as well as in its association with common risk factors across different age groups, in a large sample of Spanish working adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional study included data from 33,216 Spanish adult workers (18\u201365\u00a0years) randomly selected during voluntary routine occupational medical examinations. Sociodemographic characteristics (age and social class), anthropometric (height, weight, and waist circumference) and clinical parameters (blood pressure and serum parameters) were collected. NAFLD was determined by the validated fatty liver index (FLI) with a cut-off value of \u2265\u200960. The presence of metabolic syndrome (MetS) was assessed according to the diagnostic criteria of the International Diabetes Federation. Cardiovascular risk was determined using the REGICOR-Framingham equation. The association between FLI-defined NAFLD and risk factors by sex and age was evaluated by multivariate logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of FLI-defined NAFLD (FLI\u2009\u2265\u200960) was 19.1% overall, 27.9% (95% CI 23.3\u201328.5%) for men and 6.8% (95% CI 6.4\u20137.3%) for women and increasing across age intervals. As compared to women, men presented worse cardiometabolic and anthropometric profiles. The multivariate analysis model showed that hepatic steatosis assessed by FLI was strongly associated with age, HDL-cholesterol, social class, prediabetes, diabetes, prehypertension, hypertension, and smoking status for both men and women. The association between diabetes and hypertension with FLI-defined NAFLD was stronger in women than in men at both univariate and multivariate analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Men presented a higher prevalence of NAFLD than women across all age intervals, as well as a worse cardiometabolic profile and a higher cardiovascular risk. Nevertheless, the association between FLI-defined NAFLD and diabetes or hypertension was significantly stronger in women than in men, possibly indicating that the presence of a dysmetabolic state might affect women more than men with regard to liver outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13293-022-00475-7","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T20:19:11Z","timestamp":1667593151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study"],"prefix":"10.1186","volume":"13","author":[{"given":"Sergio","family":"Fresneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-2414","authenticated-orcid":false,"given":"Manuela","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Busquets-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"L\u00f3pez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Fuster-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bennasar-Veny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina M.","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"issue":"1","key":"475_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"475_CR2","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","volume":"65","author":"GT Brown","year":"2016","unstructured":"Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism. 2016;65(8):1080\u20136.","journal-title":"Metabolism"},{"issue":"2","key":"475_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172921","volume":"12","author":"HR Wilman","year":"2017","unstructured":"Wilman HR, Kelly M, Garratt S, Matthews PM, Milanesi M, Herlihy A, et al. Characterisation of liver fat in the UK Biobank cohort. PLoS ONE. 2017;12(2): e0172921.","journal-title":"PLoS ONE"},{"issue":"3","key":"475_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"3","key":"475_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdi.12290","volume":"6","author":"T Nishi","year":"2015","unstructured":"Nishi T, Babazono A, Maeda T, Imatoh T, Une H. Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes. J Diabetes Investig. 2015;6(3):309\u201316.","journal-title":"J Diabetes Investig"},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"2931985","DOI":"10.1155\/2016\/2931985","volume":"2016","author":"G Forlani","year":"2016","unstructured":"Forlani G, Giorda C, Manti R, Mazzella N, De Cosmo S, Rossi MC, et al. The burden of NAFLD and its characteristics in a nationwide population with type 2 diabetes. J Diabetes Res. 2016;2016:2931985.","journal-title":"J Diabetes Res"},{"issue":"6","key":"475_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198327","volume":"13","author":"J Franch-Nadal","year":"2018","unstructured":"Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-Garcia C, Mancera J, et al. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: the PREDAPS study. PLoS ONE. 2018;13(6): e0198327.","journal-title":"PLoS ONE"},{"issue":"1","key":"475_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"4","key":"475_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/HJH.0000000000001245","volume":"35","author":"R Lorbeer","year":"2017","unstructured":"Lorbeer R, Bayerl C, Auweter S, Rospleszcz S, Lieb W, Meisinger C, et al. Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease. J Hypertens. 2017;35(4):737\u201344.","journal-title":"J Hypertens"},{"issue":"2","key":"475_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.23314","volume":"51","author":"C Soderberg","year":"2010","unstructured":"Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010;51(2):595\u2013602.","journal-title":"Hepatology"},{"issue":"4","key":"475_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865\u201373.","journal-title":"Hepatology"},{"issue":"2","key":"475_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1096\/fj.15-279554","volume":"30","author":"JA Clayton","year":"2016","unstructured":"Clayton JA. Studying both sexes: a guiding principle for biomedicine. FASEB J. 2016;30(2):519\u201324.","journal-title":"FASEB J"},{"issue":"4","key":"475_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"issue":"3","key":"475_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","volume":"37","author":"A Kautzky-Willer","year":"2016","unstructured":"Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278\u2013316.","journal-title":"Endocr Rev"},{"issue":"4","key":"475_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/ajcn\/75.4.683","volume":"75","author":"I Janssen","year":"2002","unstructured":"Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 2002;75(4):683\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"475_CR16","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","volume":"34","author":"S Ballestri","year":"2017","unstructured":"Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34(6):1291\u2013326.","journal-title":"Adv Ther"},{"issue":"3","key":"475_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","volume":"63","author":"B Tramunt","year":"2020","unstructured":"Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020;63(3):453\u201361.","journal-title":"Diabetologia"},{"issue":"1","key":"475_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","volume":"22","author":"L Caballeria","year":"2010","unstructured":"Caballeria L, Pera G, Auladell MA, Toran P, Munoz L, Miranda D, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol. 2010;22(1):24\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"475_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"475_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65(8):1017\u201325.","journal-title":"Metabolism"},{"issue":"4","key":"475_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2013.05.044","volume":"59","author":"F Nascimbeni","year":"2013","unstructured":"Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59(4):859\u201371.","journal-title":"J Hepatol"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"475_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.24356","volume":"54","author":"G Calori","year":"2011","unstructured":"Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M, et al. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology. 2011;54(1):145\u201352.","journal-title":"Hepatology"},{"issue":"4","key":"475_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.4254\/wjh.v7.i4.638","volume":"7","author":"M Papagianni","year":"2015","unstructured":"Papagianni M, Sofogianni A, Tziomalos K. Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. World J Hepatol. 2015;7(4):638\u201348.","journal-title":"World J Hepatol"},{"issue":"4","key":"475_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124749","volume":"10","author":"S Jager","year":"2015","unstructured":"Jager S, Jacobs S, Kroger J, Stefan N, Fritsche A, Weikert C, et al. Association between the fatty liver index and risk of type 2 diabetes in the EPIC-Potsdam study. PLoS ONE. 2015;10(4): e0124749.","journal-title":"PLoS ONE"},{"issue":"5","key":"475_CR26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/nu12051538","volume":"12","author":"M Bennasar-Veny","year":"2020","unstructured":"Bennasar-Veny M, Fresneda S, Lopez-Gonzalez A, Busquets-Cortes C, Aguilo A, Yanez AM. Lifestyle and progression to type 2 diabetes in a cohort of workers with prediabetes. Nutrients. 2020;12(5):1538.","journal-title":"Nutrients"},{"issue":"3","key":"475_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.gaceta.2012.12.009","volume":"27","author":"A Domingo-Salvany","year":"2013","unstructured":"Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C, et al. Proposals for social class classification based on the Spanish national classification of occupations 2011 using neo-Weberian and neo-Marxist approaches. Gac Sanit. 2013;27(3):263\u201372.","journal-title":"Gac Sanit"},{"key":"475_CR28","unstructured":"Stewart A, Marfell-Jones M, Olds T, De Ridder H. International standards for anthropometric assessment; 2011."},{"key":"475_CR29","unstructured":"Obesity WHOCo, World Health O. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Geneva: World Health Organization; 2000."},{"issue":"17","key":"475_CR30","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"issue":"16","key":"475_CR31","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"key":"475_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0300-8932(03)76861-4","volume":"56","author":"JSP Marrugat","year":"2003","unstructured":"Marrugat JSP, D\u2019Agostino R, Sullivan L, Ordovas J, et al. Coronary risk estimation in Spain using a calibrated Framingham function. Rev Esp Cardiol. 2003;56:253\u201361.","journal-title":"Rev Esp Cardiol"},{"issue":"9","key":"475_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"475_CR34","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37(5):1202\u201319.","journal-title":"Hepatology"},{"issue":"2","key":"475_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1665-2681(19)32110-6","volume":"3","author":"G Bedogni","year":"2004","unstructured":"Bedogni G, Bellentani S. Fatty liver: how frequent is it and why? Ann Hepatol. 2004;3(2):63\u20135.","journal-title":"Ann Hepatol"},{"issue":"2","key":"475_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2000","unstructured":"Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med. 2000;132(2):112\u20137.","journal-title":"Ann Intern Med"},{"issue":"1","key":"475_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44\u201352.","journal-title":"Hepatology"},{"issue":"3","key":"475_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MOG.0000000000000176","volume":"31","author":"IH Kim","year":"2015","unstructured":"Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31(3):184\u201391.","journal-title":"Curr Opin Gastroenterol"},{"issue":"9","key":"475_CR39","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/MEG.0000000000000151","volume":"26","author":"Z Wang","year":"2014","unstructured":"Wang Z, Xu M, Hu Z, Hultstrom M, Lai E. Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China. Eur J Gastroenterol Hepatol. 2014;26(9):1015\u201321.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"475_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","volume":"43","author":"JG Fan","year":"2005","unstructured":"Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005;43(3):508\u201314.","journal-title":"J Hepatol"},{"issue":"5","key":"475_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","volume":"47","author":"Y Eguchi","year":"2012","unstructured":"Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol. 2012;47(5):586\u201395.","journal-title":"J Gastroenterol"},{"issue":"39","key":"475_CR42","doi-asserted-by":"publisher","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","volume":"20","author":"M Bertolotti","year":"2014","unstructured":"Bertolotti M, Lonardo A, Mussi C, Baldelli E, Pellegrini E, Ballestri S, et al. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol. 2014;20(39):14185\u2013204.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"475_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/cen.12698","volume":"83","author":"J Puig","year":"2015","unstructured":"Puig J, Blasco G, Daunis IEJ, Loshuertos E, Codina J, Cuba V, et al. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. Clin Endocrinol (Oxf). 2015;83(2):180\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"475_CR44","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/cells8101259","volume":"8","author":"C Lee","year":"2019","unstructured":"Lee C, Kim J, Jung Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Cells. 2019;8(10):1259.","journal-title":"Cells"},{"issue":"7","key":"475_CR45","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","volume":"20","author":"S Ballestri","year":"2014","unstructured":"Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(7):1724\u201345.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"475_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jhep.2007.02.007","volume":"47","author":"JY Lee","year":"2007","unstructured":"Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol. 2007;47(2):239\u201344.","journal-title":"J Hepatol"},{"key":"475_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/131528","volume":"2015","author":"GE Chung","year":"2015","unstructured":"Chung GE, Yim JY, Kim D, Lim SH, Yang JI, Kim YS, et al. The influence of metabolic factors for nonalcoholic fatty liver disease in women. Biomed Res Int. 2015;2015: 131528.","journal-title":"Biomed Res Int"},{"issue":"8","key":"475_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.endonu.2016.06.001","volume":"63","author":"J Caballeria","year":"2016","unstructured":"Caballeria J, Caballeria L. Nonalcoholic steatohepatitis and diabetes. Endocrinol Nutr. 2016;63(8):377\u20139.","journal-title":"Endocrinol Nutr"},{"issue":"6","key":"475_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10(6):330\u201344.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"475_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-230X-10-56","volume":"10","author":"B Balkau","year":"2010","unstructured":"Balkau B, Lange C, Vol S, Fumeron F, Bonnet F. Nine-year incident diabetes is predicted by fatty liver indices: the French DESIR study. BMC Gastroenterol. 2010;10:56.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"475_CR51","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/liv.12619","volume":"35","author":"J Fung","year":"2015","unstructured":"Fung J, Lee CK, Chan M, Seto WK, Lai CL, Yuen MF, et al. High prevalence of non-alcoholic fatty liver disease in the Chinese\u2014results from the Hong Kong liver health census. Liver Int. 2015;35(2):542\u20139.","journal-title":"Liver Int"},{"issue":"6","key":"475_CR52","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11892-015-0607-4","volume":"15","author":"C Saponaro","year":"2015","unstructured":"Saponaro C, Gaggini M, Gastaldelli A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. Curr Diabetes Rep. 2015;15(6):607.","journal-title":"Curr Diabetes Rep"},{"issue":"2","key":"475_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","volume":"68","author":"A Lonardo","year":"2018","unstructured":"Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018;68(2):335\u201352.","journal-title":"J Hepatol"},{"issue":"6","key":"475_CR54","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MCO.0000000000000317","volume":"19","author":"C Ding","year":"2016","unstructured":"Ding C, Chan Z, Magkos F. Lean, but not healthy: the \u2018metabolically obese, normal-weight\u2019 phenotype. Curr Opin Clin Nutr Metab Care. 2016;19(6):408\u201317.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"475_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2042-6410-3-13","volume":"3","author":"K Karastergiou","year":"2012","unstructured":"Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues\u2014the biology of pear shape. Biol Sex Differ. 2012;3(1):13.","journal-title":"Biol Sex Differ"},{"issue":"8","key":"475_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045498","volume":"11","author":"C Busquets-Cortes","year":"2021","unstructured":"Busquets-Cortes C, Bennasar-Veny M, Lopez-Gonzalez AA, Fresneda S, Aguilo A, Yanez A. Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes. BMJ Open. 2021;11(8): e045498.","journal-title":"BMJ Open"},{"issue":"3","key":"475_CR57","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","volume":"59","author":"R Pais","year":"2013","unstructured":"Pais R, Charlotte F, Fedchuk L, Bedossa P, Lebray P, Poynard T, et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol. 2013;59(3):550\u20136.","journal-title":"J Hepatol"},{"issue":"3","key":"475_CR58","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792\u20138.","journal-title":"Hepatology"},{"key":"475_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbacli.2014.09.001","volume":"3","author":"GB Goh","year":"2015","unstructured":"Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, et al. Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients. BBA Clin. 2015;3:141\u20135.","journal-title":"BBA Clin"},{"issue":"6","key":"475_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.endinu.2017.12.011","volume":"65","author":"R Aller de la Fuente","year":"2018","unstructured":"Aller de la Fuente R, Mora Cuadrado N, Tafur C, Lopez Gomez JJ, Gomez de la Cuesta S, Garcia Sanchez MC, et al. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Endocrinol Diabetes Nutr. 2018;65(6):354\u201360.","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"17","key":"475_CR61","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3390\/ijerph16173104","volume":"16","author":"C Tana","year":"2019","unstructured":"Tana C, Ballestri S, Ricci F, Di Vincenzo A, Ticinesi A, Gallina S, et al. Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications. Int J Environ Res Public Health. 2019;16(17):3104.","journal-title":"Int J Environ Res Public Health"},{"issue":"39","key":"475_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008179","volume":"96","author":"W Dai","year":"2017","unstructured":"Dai W, Ye L, Liu A, Wen SW, Deng J, Wu X, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine (Baltimore). 2017;96(39): e8179.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"475_CR63","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ando.2020.07.1109","volume":"81","author":"W Hu","year":"2020","unstructured":"Hu W, Liu Z, Hao HR, Yu WN, Wang XQ, Shao XJ, et al. Correlation between income and non-alcoholic fatty liver disease in a Chinese population. Ann Endocrinol (Paris). 2020;81(6):561\u20136.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"3","key":"475_CR64","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/MPG.0000000000002527","volume":"70","author":"S Orkin","year":"2020","unstructured":"Orkin S, Brokamp C, Yodoshi T, Trout AT, Liu C, Meryum S, et al. Community socioeconomic deprivation and nonalcoholic fatty liver disease severity. J Pediatr Gastroenterol Nutr. 2020;70(3):364\u201370.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"475_CR65","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/ijerph18041892","volume":"18","author":"J Cho","year":"2021","unstructured":"Cho J, Lee I, Park DH, Kwak HB, Min K. Relationships between socioeconomic status, handgrip strength, and non-alcoholic fatty liver disease in middle-aged Adults. Int J Environ Res Public Health. 2021;18(4):1892.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"475_CR66","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/hep4.1831","volume":"6","author":"AM Giammarino","year":"2022","unstructured":"Giammarino AM, Qiu H, Bulsara K, Khan S, Jiang Y, Da BL, et al. Community socioeconomic deprivation predicts nonalcoholic steatohepatitis. Hepatol Commun. 2022;6(3):550\u201360.","journal-title":"Hepatol Commun"},{"issue":"3","key":"475_CR67","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/geronb\/gby108","volume":"75","author":"YC Yang","year":"2020","unstructured":"Yang YC, Schorpp K, Boen C, Johnson M, Harris KM. Socioeconomic status and biological risks for health and illness across the life course. J Gerontol B Psychol Sci Soc Sci. 2020;75(3):613\u201324.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"3","key":"475_CR68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41395-018-0283-5","volume":"114","author":"HS Jung","year":"2019","unstructured":"Jung HS, Chang Y, Kwon MJ, Sung E, Yun KE, Cho YK, et al. Smoking and the risk of non-alcoholic fatty liver disease: a cohort study. Am J Gastroenterol. 2019;114(3):453\u201363.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"475_CR69","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00535-011-0376-z","volume":"46","author":"A Hamabe","year":"2011","unstructured":"Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, et al. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol. 2011;46(6):769\u201378.","journal-title":"J Gastroenterol"},{"issue":"32","key":"475_CR70","first-page":"5196","volume":"12","author":"NC Chavez-Tapia","year":"2006","unstructured":"Chavez-Tapia NC, Lizardi-Cervera J, Perez-Bautista O, Ramos-Ostos MH, Uribe M. Smoking is not associated with nonalcoholic fatty liver disease. World J Gastroenterol. 2006;12(32):5196\u2013200.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"475_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jim-2016-000213","volume":"65","author":"H Shen","year":"2017","unstructured":"Shen H, Peng JL, Tayarachakul S, Liangpunsakul S. Association between serum cotinine level and prevalence of non-alcoholic fatty liver disease: a cross-sectional study from the third national health and nutrition examination survey. J Investig Med. 2017;65(1):43\u20138.","journal-title":"J Investig Med"},{"issue":"1","key":"475_CR72","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-17-0166","volume":"235","author":"A Stojakovic","year":"2017","unstructured":"Stojakovic A, Espinosa EP, Farhad OT, Lutfy K. Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol. 2017;235(1):R13\u201331.","journal-title":"J Endocrinol"},{"issue":"1","key":"475_CR73","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/ijoem.IJOEM_53_16","volume":"21","author":"R Chowdhury","year":"2017","unstructured":"Chowdhury R, Shah D, Payal AR. Healthy worker effect phenomenon: revisited with emphasis on statistical methods\u2014a review. Indian J Occup Environ Med. 2017;21(1):2\u20138.","journal-title":"Indian J Occup Environ Med"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-022-00475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-022-00475-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-022-00475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T12:05:20Z","timestamp":1667736320000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-022-00475-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s13293-022-00475-7","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Balearic Ethical Committee of Clinical Research (Ref. No: CEI-IB-1887). All participants provided written informed consent prior to enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}